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Basic and applied cancer research are critically dependent
upon methods to detect the size together with molecular
and functional parameters of primary tumor lesions and
metastases. For more than 150 years, the cellular basis of
cancer growth and progression was predominantly studied
using histopathological analysis of cells and tissues after
fixation and staining. Only over the past decade, the advent
of long-term 3D culture techniques, innovative live-cell
multi-dimensional microscopy, and fluorescent reporter
strategies have caused a middle-sized revolution in cancer
research providing access to cell structure and function
with cellular and subcellular resolution to living cells and
molecules in 3D tissue environments in vitro and in vivo.
Consequently, dynamic imaging has provided novel and
often surprising insight into the hallmarks of cancer pro-
gression and metastatic dissemination. All authors articles
included in this special issue of Clinical and Experimental
Metastasis have substantially contributed to this progress.
Old and often complicated questions begin to be eluci-
dated, literally. How do cancer cells invade tissue? How do
they coordinate their cytoskeleton with intracellular and
extracellular proteases and adhesion cascades to generate a
particular morphology and overcome tissue barriers? How
do cancer cells coopt the tumor microenvironment and
mislead the immune defense to maintain tolerance rather
than effective cytotoxic killing? How do metastatic seeding
and cross-talk with the stroma of secondary sites lead to
macroscopic outgrowth of life-threatening metastasis?
Lastly and importantly, how can we translate this knowl-
edge to identify and validate targeted single- and multi-
modality therapy and combat cancer disease? The articles
included in this special issue of CEM cover the spectrum
from subcellular to whole-body imaging and discuss key
aspects of cancer imaging in basic reseach and preclinical
drug discovery.
The most basic basic process underlying cancer invasion
and metastasis is a dynamic actomyosin cytoskeleton that,
in response to external factors, drives cell polarity, turn
over of cell matrix interactions and migration of cancer
cells away from the primary lesion into surrounding tissues
and blood and lymph vasculature. Olson and Sahai [1]
review intracellular regulators of the actin cytoskeleton in
cancer using modern 3D in vitro culture and intravital
models monitored by sensitive microscopy. Whereas their
specific role in the invasion cascade remains to be deter-
mined, it appears likely that at least some actin regulators
drive particular steps of metastatic dissemination and cel-
lular adaptation responses and, therefore, could be
amenable for therapeutic targeting.
Besides mechanical coupling of the cell to its environ-
ment, the actin cytoskeleton also provides a scaffold that
coordinates adhesion and proteolytic events at the cell
surface. Whereas most studies address the location and
function of surface proteases in 2D models which probably
are inappropriate to capture cancer cell invasion into the
tissue stroma, Wolf and Friedl [2] show how 3D multi-
modal confocal microscopy allows to identify location,
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function and structural consequences of collagenase
activity in cancer cell migration. These studies provide a
subcellular-resolved map of quite different actin-rich pro-
teolytic cell structures that execute tissue remodeling
during invasion.
Cancer cell-derived proteases including matrix
metalloproteinases, serine proteases and cathepsins further
execute important functions in protein processing and cell–
cell communication. Sameni et al. [3] present a live-cell
coculture model to dyamically monitor where and how
different protease classes become upregulated and acti-
vated at the interface between cancer cells, extracellular
matrix, and reactive stroma cells. Because in many cancer
types upregulated proteases are strongly associated with
cancer progression and poor outcome, such methodology
may be useful for screening up- and downsstream regula-
tors of the tumor-stroma interaction and the identification
of drugs that may inhibit this tumor-promoting process.
As concequence of a deregulated tumor-stroma margin,
the normal tissue structure becomes replaced by a reactive
de-novo tissue comprising activated stromal cells, not
dissimilar to chronic non-healing wounds. Advanced
spectrally resolved multiphoton microscopy and the
detection of the fluorescence life-time can decipher an
emission ‘‘signature’’ of both, tumor, tumor-stroma and
tumor-associated cells in life tissues. Highlighting fluo-
rescence lifetime microscopy, Provenzano et al. [4] review
the technology of multiphoton imaging and provide
examples of disorganized tumor stroma from mouse
models of cancer that may be instrumental in future diag-
nostic and therapeutic monitoring of preclincal and clinical
samples.
Concommitant to cancer progression, many cancer types
show an increased infiltration of activated cytotoxic T
lymphocates that recognize tumor-associated antigens but
fail to eliminate the disease. Mempel and Bauer [5] sum-
marize dynamic experimental models and imaging
techniques that allow to dynamically visualize immune-cell
activation and killing of cancer cells. Besides providing
better insight into immune escape strategies of cancer
lesions, these approaches will also help to identify mech-
anisms of cell delivery and pharmacological interference to
improve both, endogenous anti-tumor immune responses
and adoptive cell delivery in cancer immunotherapy.
A traditional approach to visualize kinetic events in
vascular biology in small animal models is the dorsal
skin-fold chamber, which also provides direct optical
access to cancer growth and regression and the reactive
tumor stroma. Koehl and Geissler [6] review the tech-
nique of the skin-fold chamber, discuss stengths and
pitfalls of the approach, and provide compelling examples
for the use of dynamic imaging of the tumor vasculature
and cancer growth in preclinical drug discovery. Anti-
angiogenic therapy using inhibition of the mTor pathway
has served as role model for a wealth of subsequent
preclinical studies to detect principles and inhibition
regimens of cancer progression.
Besides advances in microscopy, the introduction of
fluorescent tumor models has revolutionized long-term
monitoring of cancer progression and regression in small
animal models. Robert Hoffman has pioneered the use of
single- and dual-color tumor models in, often, fluorescent
mouse models for non-invasive and invasive optical
imaging. These studies have provided insight into mech-
anisms of cancer progression and regression. Here, he
reviews the instrumentation allowing fluorescent imaging
of different steps of cancer progression and metastasis in
live animals, its use in different orthotopic models, and
preclinical therapy of metastatic cancer progression and
relapse [7].
After distant seeding, the growth of metastases is the
main cause for lethality. Therefore, an understanding of
organ-preferential seeding and growth is most relevant for
targeting progressive cancer disease. Non-invasive mul-
timodality imaging of live tumors in small animal models,
such as combining computer tomography with biolumi-
nescence imaging, has strongly enhanced our
understanding of the mechanisms driving fatal outcome.
Kaitzel and collegues [8] review current approaches of
multimodality imaging in basic research and drug dis-
covery, exemplified by bone metastasis and its treatment
with bisphophonates. These imaging approaches are fur-
ther instrumental in developing novel probes to monitor
and target human cancer disease.
Modern live-cell imaging technology has not only
boosted academic cancer research but also is being
implemented into the drug discovery pipeline of the
pharmaceutical industry. Neil O. Gallagher features the
combination and sequence of approaches used for large-
scale screening and discovery of new compounds to tar-
get cancer invasion and metastatic progression [9].
Besides an impressive complementary infrastructure to
monitor different cell functions in 3D models, image
postprocessing, quantification and bioinformatic integra-
tion are key elements of modern drug discovery. Such
technology will further help to define multi-targeted
therapy using validated 3D models with in vivo
relevance.
In summary, academic and applied cancer research
greatly depend upon 3D cell culture techniques and
imaging approaches which progressively complement and,
in part, replace traditional strategies. I hope this special
issue will be an eye-opening, fascinating introduction to a
better-resolved and dynamic understanding of cancer dis-
ease during progression and, hopefully, therapy-induced
regression.
270 Clin Exp Metastasis (2009) 26:269–271
123
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Olsen MF, Sahai E (2009) The actin cytoskeleton in cancer cell
motility. Clin Exp Metast. doi:10.1007/s10585-008-9174-2
2. Wolf K, Friedl P (2009) Mapping proteolytic cancer cell-
extracellular matrix interfaces. Clin Exp Metast. doi:10.1007/
s10585-008-9190-2
3. Sameni M, Cavallo-Medved D, Dosescu J, Jedeszko C, Moin K,
Mullins SR, Olive MB, Rudy D, Sloane BF (2009) Imaging and
quantifying the dynamics of tumor-associated proteolysis. Clin
Exp Metast. doi:10.1007/s10585-008-9218-7
4. Provenzano PP, Eliceiri KW, Keely PJ (2009) Multiphoton
microscopy and fluorescence lifetime imaging microscopy (FLIM)
to monitor metastasis and the tumor microenvironment. Clin Exp
Metast. doi:10.1007/s10585-008-9204-0
5. Mempel TR, Bauer CA (2009) Intravital imaging of CD8? T cell
function in cancer. Clin Exp Metast. doi:10.1007/s10585-008-
9196-9
6. Koehl GE, Gaumann A, Geissler EK (2009) Intravital microscopy
of tumor angiogenesis and regression in the dorsal skin fold
chamber: mechanistic insights and preclinical testing of therapeu-
tic strategies. Clin Exp Metast. doi:10.1007/s10585-008-9234-7
7. Hoffman RM (2009) Imaging cancer dynamics in vivo at the
tumor and cellular level with fluorescent proteins. Clin Exp
Metast. doi:10.1007/s10585-008-9205-z
8. Kaijzel EL, Snoeks TJA, Buijs JT, van der Pluijm G, Lowik
CWGM (2009) Multimodal imaging and treatment of bone
metastasis. Clin Exp Metast. doi:10.1007/s10585-008-9217-8
9. Carragher NO (2009) Profiling distinct mechanisms of tumour
invasion for drug discovery: imaging adhesion, signalling and
matrix turnover. Clin Exp Metast. doi:10.1007/s10585-008-9222-y
Clin Exp Metastasis (2009) 26:269–271 271
123
